• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[SEN Guidelines. Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic renal disease patients].

作者信息

Torregrosa José-Vicente, Cannata Andia Jorge, Bover Jordi, Caravaca Francisco, Lorenzo Víctor, Martín de Francisco Angel Luis, Martín-Malo Alejandro, Martínez Isabel, González Parra Emilio, Fernández Giráldez Elvira, Rodríguez Portillo Mariano

机构信息

Hospital Clínic, Barcelona.

出版信息

Nefrologia. 2008;28 Suppl 1:1-22.

PMID:18338978
Abstract
摘要

相似文献

1
[SEN Guidelines. Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic renal disease patients].[SEN指南：西班牙肾脏病学会关于慢性肾病患者骨矿物质代谢改变管理的建议]
Nefrologia. 2008;28 Suppl 1:1-22.
2
[Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed].[慢性肾脏病所致矿物质和骨病的管理：有哪些促成的建议]
Nephrol Ther. 2008 Sep;4 Spec No 1:2-8, 15-9.
3
Bone mineral metabolism in the neonate: calcium, phosphorus, magnesium, and alkaline phosphatase.新生儿的骨矿物质代谢：钙、磷、镁与碱性磷酸酶。
Neonatal Netw. 2008 Jan-Feb;27(1):57-63. doi: 10.1891/0730-0832.27.1.57.
4
Calcium and phosphorus metabolism in patients who have chronic kidney disease.患有慢性肾病患者的钙磷代谢
Med Clin North Am. 2005 May;89(3):631-47. doi: 10.1016/j.mcna.2004.12.005.
5
[Complications suffered by dialysis patients. 3. Ca and P metabolism disorders of bone].
Nihon Naika Gakkai Zasshi. 2000 Jul 10;89(7):1358-65.
6
Disorders of calcium and phosphate metabolism in childhood and adolescence.儿童和青少年钙磷代谢紊乱
Major Probl Clin Pediatr. 1979;20:1-314.
7
Calcium and phosphorus derangements.
Crit Care Nurs Clin North Am. 1994 Dec;6(4):747-66.
8
Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview.慢性肾脏病骨代谢与疾病临床实践指南：概述
Pharmacotherapy. 2005 Dec;25(12):1687-707. doi: 10.1592/phco.2005.25.12.1687.
9
Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.).西班牙肾脏病学会关于慢性肾脏病患者矿物质和骨异常控制的建议（S.E.N.-M.B.D.）
Nefrologia. 2011;31 Suppl 1:3-32. doi: 10.3265/Nefrologia.pre2011.Jan.10816.
10
Disorders of calcium and phosphorus homeostasis.钙磷稳态紊乱
Pediatr Clin North Am. 1990 Dec;37(6):1441-65. doi: 10.1016/s0031-3955(16)37019-5.

引用本文的文献

1
Adynamic bone disorder in chronic kidney disease: meta-analysis and narrative review of potential biomarkers as diagnosis and therapeutic targets.慢性肾脏病中的动力缺失性骨病：作为诊断和治疗靶点的潜在生物标志物的荟萃分析与叙述性综述
Ren Fail. 2025 Dec;47(1):2530162. doi: 10.1080/0886022X.2025.2530162. Epub 2025 Jul 16.
2
The true cost of phosphate control in chronic kidney disease.慢性肾脏病中磷酸盐控制的真实成本。
Clin Kidney J. 2025 Mar 13;18(Suppl 1):i46-i60. doi: 10.1093/ckj/sfae434. eCollection 2025 Mar.
3
Vertebral fractures in patients with CKD and the general population: a call for diagnosis and action.
慢性肾脏病患者与普通人群中的椎体骨折：呼吁诊断与行动。
Clin Kidney J. 2024 Jul 9;17(8):sfae191. doi: 10.1093/ckj/sfae191. eCollection 2024 Aug.
4
Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease-Mineral and Bone Disorder in Non-Dialysis Adult Patients.非透析成年患者慢性肾脏病 - 矿物质和骨异常诊断与管理中使用的当前及新出现的标志物和工具
J Clin Med. 2023 Sep 30;12(19):6306. doi: 10.3390/jcm12196306.
5
Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis.慢性肾脏病骨病的病理生理学：从基础到肾性骨营养不良和骨质疏松症。
Front Physiol. 2023 Jun 5;14:1177829. doi: 10.3389/fphys.2023.1177829. eCollection 2023.
6
Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s.非透析慢性肾脏病继发甲状旁腺功能亢进症的治疗：2022 年评价。
Nephrol Dial Transplant. 2023 May 31;38(6):1397-1404. doi: 10.1093/ndt/gfac236.
7
Mineral and bone disorder and longterm survival in a chronic kidney disease grade 3b-4cohort.矿物质和骨代谢紊乱与慢性肾脏病 3b-4 期患者的长期生存
Ren Fail. 2022 Dec;44(1):1356-1367. doi: 10.1080/0886022X.2022.2107543.
8
Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics.COVID-19 血液透析患者的死亡率：帕立骨化醇或钙敏感受体激动剂的影响。
Nutrients. 2021 Jul 26;13(8):2559. doi: 10.3390/nu13082559.
9
Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism.西那卡塞在非透析慢性肾脏病合并继发性甲状旁腺功能亢进患者中的长期疗效
Kidney Res Clin Pract. 2019 Jun 30;38(2):229-238. doi: 10.23876/j.krcp.18.0088.
10
A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients.在维持性血液透析患者中，完整甲状旁腺激素（iPTH）水平降低与较高的死亡率相关。
PLoS One. 2017 Mar 24;12(3):e0173831. doi: 10.1371/journal.pone.0173831. eCollection 2017.